The Cooper Companies, Inc. (NASDAQ:COO) CAO Sells $172,956.03 in Stock

The Cooper Companies, Inc. (NASDAQ:COO) CAO Agostino Ricupati sold 1,601 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total value of $172,956.03. Following the completion of the transaction, the chief accounting officer now owns 4,818 shares in the company, valued at approximately $520,488.54. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Cooper Companies Price Performance

COO stock opened at $108.51 on Thursday. The stock has a 50-day moving average price of $94.63 and a two-hundred day moving average price of $94.87. The Cooper Companies, Inc. has a 1 year low of $75.93 and a 1 year high of $108.68. The stock has a market cap of $21.61 billion, a PE ratio of 63.83, a price-to-earnings-growth ratio of 2.55 and a beta of 0.98. The company has a current ratio of 1.99, a quick ratio of 1.18 and a debt-to-equity ratio of 0.33.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.91 by $0.05. The business had revenue of $1 billion during the quarter, compared to the consensus estimate of $997.30 million. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. Cooper Companies’s quarterly revenue was up 7.8% on a year-over-year basis. During the same period last year, the company earned $0.84 earnings per share. Equities analysts forecast that The Cooper Companies, Inc. will post 3.66 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on COO shares. Piper Sandler raised their target price on shares of Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a research note on Thursday, August 29th. Jefferies Financial Group raised shares of Cooper Companies from a “hold” rating to a “buy” rating and raised their price objective for the company from $107.00 to $115.00 in a research note on Tuesday, July 16th. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research report on Thursday, August 29th. Robert W. Baird raised their price target on Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a research report on Thursday, August 29th. Finally, Morgan Stanley lifted their price objective on Cooper Companies from $95.00 to $104.00 and gave the stock an “equal weight” rating in a research note on Tuesday. Four equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $115.00.

Institutional Trading of Cooper Companies

A number of institutional investors have recently made changes to their positions in COO. Sanctuary Advisors LLC acquired a new stake in Cooper Companies in the 2nd quarter valued at $3,043,000. Cetera Investment Advisers raised its holdings in Cooper Companies by 6.3% during the second quarter. Cetera Investment Advisers now owns 22,244 shares of the medical device company’s stock worth $1,942,000 after acquiring an additional 1,309 shares in the last quarter. B. Riley Wealth Advisors Inc. boosted its position in Cooper Companies by 113.1% during the second quarter. B. Riley Wealth Advisors Inc. now owns 2,529 shares of the medical device company’s stock valued at $221,000 after purchasing an additional 1,342 shares during the last quarter. Quarry LP increased its position in shares of Cooper Companies by 1,225.9% during the 2nd quarter. Quarry LP now owns 2,718 shares of the medical device company’s stock worth $237,000 after purchasing an additional 2,513 shares during the last quarter. Finally, Wallace Advisory Group LLC bought a new stake in shares of Cooper Companies during the 2nd quarter worth approximately $290,000. Institutional investors own 24.39% of the company’s stock.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.